Health-related quality of life, anxiety, and depressive symptoms in children with primary immunodeficiencies
- PMID: 24669189
- PMCID: PMC3962310
- DOI: 10.2147/PPA.S58040
Health-related quality of life, anxiety, and depressive symptoms in children with primary immunodeficiencies
Abstract
Introduction: The aims of this study were to evaluate levels of health-related quality of life (HRQOL) and the presence of anxiety and depressive symptoms in children with primary immunodeficiency disease (PID) in Serbia.
Materials and methods: Self- and parent-rated data from 25 children with PID were available. As controls, data from 50 children with juvenile idiopathic arthritis (JIA) and 89 healthy children were included. The Pediatric Quality of Life Inventory was used for HRQOL assessments. Anxiety symptoms were identified using the Screen for Child Anxiety-Related Emotional Disorders questionnaire, while depressive symptoms were identified using the Mood and Feeling Questionnaire.
Results: Children with PID had significantly lower Pediatric Quality of Life Inventory total scores compared to children with JIA and healthy children as child-rated (P=0.02) and parent-rated (P<0.001). Specifically, they had significantly lowered emotional functioning compared to children with JIA, and social functioning compared to both children with JIA and healthy children. School functioning was significantly lower among children with PID (parent-rated only). By parent-rated responses, six (24%) out of 25 children with PID had significant anxiety symptoms, while five (20%) children had significant depressive symptoms, which was statistically higher than among children with JIA and healthy controls (P=0.05).
Conclusion: HRQOL could be significantly compromised in children with PID, particularly across such psychosocial domains as emotional, social, and school. These children were also found to be at an increased risk for suffering significant anxiety and depressive symptoms.
Keywords: anxiety; children; depression; primary immunodeficiency disease; quality of life.
Similar articles
-
Depression And Anxiety In Patients With Juvenile Idiopathic Arthritis: Current Insights And Impact On Quality Of Life, A Systematic Review.Open Access Rheumatol. 2019 Nov 1;11:237-252. doi: 10.2147/OARRR.S174408. eCollection 2019. Open Access Rheumatol. 2019. PMID: 31807093 Free PMC article. Review.
-
Health-related quality of life and emotional problems in juvenile idiopathic arthritis.Qual Life Res. 2013 Apr;22(3):607-12. doi: 10.1007/s11136-012-0172-0. Epub 2012 Apr 7. Qual Life Res. 2013. PMID: 22485026
-
Use of PROMIS® to screen for depression in children with arthritis.Pediatr Rheumatol Online J. 2020 Nov 23;18(1):92. doi: 10.1186/s12969-020-00482-1. Pediatr Rheumatol Online J. 2020. PMID: 33228749 Free PMC article.
-
Health-Related Quality of Life in Children and Adults with Primary Immunodeficiencies: A Systematic Review and Meta-Analysis.J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1929-1957.e5. doi: 10.1016/j.jaip.2019.02.013. Epub 2019 Feb 20. J Allergy Clin Immunol Pract. 2019. PMID: 30797077
-
Psychological burden of pediatric primary immunodeficiency.Pediatr Int. 2018 Oct;60(10):911-917. doi: 10.1111/ped.13675. Epub 2018 Oct 4. Pediatr Int. 2018. PMID: 30103264
Cited by
-
Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages".Orphanet J Rare Dis. 2016 Jun 22;11(1):83. doi: 10.1186/s13023-016-0452-9. Orphanet J Rare Dis. 2016. PMID: 27334100 Free PMC article.
-
A clinician's guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases.Allergy Asthma Clin Immunol. 2022 Sep 30;18(1):87. doi: 10.1186/s13223-022-00726-7. Allergy Asthma Clin Immunol. 2022. PMID: 36180928 Free PMC article. Review.
-
Depression And Anxiety In Patients With Juvenile Idiopathic Arthritis: Current Insights And Impact On Quality Of Life, A Systematic Review.Open Access Rheumatol. 2019 Nov 1;11:237-252. doi: 10.2147/OARRR.S174408. eCollection 2019. Open Access Rheumatol. 2019. PMID: 31807093 Free PMC article. Review.
-
Provider Perceptions of Quality of Life, Neurocognition, Physical Well-being, and Psychosocial Health in Patients with Primary Immunodeficiency/Immune Dysregulation Conditions.J Clin Immunol. 2019 Nov;39(8):805-813. doi: 10.1007/s10875-019-00703-7. Epub 2019 Oct 26. J Clin Immunol. 2019. PMID: 31655959
-
Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies.J Clin Immunol. 2018 Nov;38(8):886-897. doi: 10.1007/s10875-018-0562-3. Epub 2018 Nov 21. J Clin Immunol. 2018. PMID: 30465179 Free PMC article.
References
-
- Conly ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies) Clin Immunol. 1999;93:190–197. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials